Medical Hypotheses
Volume 59, Issue 6 , Pages 655-659 , 12 November 2002

Assessment of the disturbances in metabolic homeostasis: a hypothesis of synergism

  • S.R Kim

      Affiliations

    • University of Pittsburgh, Pittsburgh, USA
    • Corresponding Author InformationCorrespondence to: S. R. Kim, PhD. 102 Woodshine Drive, Pittsburgh, PA 15215, USA
    • ,
  • E.O Talbott

      Affiliations

    • University of Pittsburgh, Pittsburgh, USA
    • ,
  • E.S Tull

      Affiliations

    • University of Pittsburgh, Pittsburgh, USA
    • ,
  • J.V Zborowski

      Affiliations

    • University of Pittsburgh, Pittsburgh, USA
    • ,
  • M.T Vogt

      Affiliations

    • University of Pittsburgh, Pittsburgh, USA
    • Department of Orthopedic Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, USA
    • ,
  • L.H Kuller

      Affiliations

    • University of Pittsburgh, Pittsburgh, USA

Received 15 May 2001 ,Accepted 11 January 2002.

References 

  1. DeFronzo RA, Tobin JD, Andres R. Glucose clamp techniques: a method for quanitifying insulin secretion and resistance. Am. J. Physiol. 1979;237:E214–E223
  2. Hosker DR, Mathew DR, Rudenski AS. continuous infusion of glucose with model assessment: Measurement of insulin resistance and beta cell function in man. Diabetologia. 1985;28:401–411
  3. Mathew DR, Hosker DR, Rudenski AS. Homeostasis model assessment insulin resistance and beta cell function from fasting glucose and insulin concentration in man. Diabetologia. 1985;28:412–419
  4. Kim S. R., Tull E. S., Tablbott E. O., Vogt M. T., Kuller H. L. Interrelationship of T3 and insulin to disturbances in metabolic homeostasis. (Article in this volume of Med Hypothesis)
  5. Rewers M, Hanmman RF. Risk factors for NIDDM. In: Diabetes in America. 2nd Edn.. 1995;p. 179–220
  6. Pilkis SJ, El-Maghrabi MR, Claus TH. Fructose-2,3-biphosphate in control of hepatic gluconeogenesis: from metabolites to molecular genetics. Diabetes Care. 1990;13:588–599
  7. Groop LC, Kaankuri M, Schalin JC. Association between polymorphism of the glycogen synthase gene and NIDDM. N. Engl. J. Med. 1993;328:11014
  8. Sherrat HAS, Bartlett K. Metabolic regulation. In:  Cohen RD,  Lewis B,  Alberti KGMM,  Denmann AM editor. The Metabolic and Molecular Basis of Acquired Diseases. London: Baillie’re Tindall; 1990;p. 300–320
  9. Groot LJ, Jameson JL. Mechanism of thyroid hormone action. In: Endocrinology. 3rd Edn.. Leslie Degroot, Philadelphia, PA: W.B. Sunders; 1995;p. 1–64 583–601
  10. Granner DK, Pikis S. The genes of hepatic glucose metabolism. J. Biol. Chem. 1990;265:10173–10182
  11. Manson JE, Willett WC, Stampler MJ. Body weight and mortality among women. N. Eng. J. Med. 1995;333:677–685
  12. De Vegt F, Dekker JM, Coen DA. Similar 9-year mortality risks and reproducibility for WHR and ADA glucose tolerance categories. Diabetes Care. 2000;23:40–44
  13. Haffner SM, Mietenen H, Stern MP. The homeostasis model in the San Antonio Heart study. Diabetes Care. 1997;20:1087–1092
  14. Bonora ET, Archer G, Alberiche M. Homeostasis model assessment closely mirrors the glucose camp technique in the assessment of insulin sensitivity. Diabetes Care. 2000;23:57–63
  15. Rrodsky GM, Batts AA, Bennet LL. Effects of carbohydrates on secretion of insulin from isolated rat pancrease. Am. J. Physiol. 1963;205:638–644
  16. Reaven GM, Hollenbeck CB, Chen YD. Relationship between tolerance, insulin secretion, and isnulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia. 1989;32:52–55
  17. Pimenta W, Mitrakon A, Jensen T. Insulin secretion and insulin deficiency in people with impaired glucose tolerance. Diabet. Med. 1996;13:S33–S36
  18. Thomson AL, Cooney GJ. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. Diabetes. 2000;49:1761–1765
  19. Hiroes YH, Lindsey RL, Yoshitaka N, Johnson JH, Unger RH. Defective fatty acid-mediated beta cell compensation in Zucker diabetic fatty acid rate pathogenic implication for obesity-dependent diabetes. J. Biol. Chem. 1996;217:5633–5637
  20. Pan DA, Lilliolja S, Krikrtos AD, Miller MR, Bauer LA, Borgadus C. Skeletal muscle trigyceirdes levels are inversely related to insulin action. Diabetes. 1997;983–988
  21. Philip DL, Caddy S, Illic V, Fielding BA, Frayn KN, Borth wick AC. Intramuscular triglyceride and muscle insulin sensitivity: evidence for relationship in nondiabetic subjects. Metabolisms. 1996;45:947–950
  22. Olesky J. M., Farquhar J. W., Raven G. M. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57: 551–560
  23. Sharp GW. The adenylate cyclase-cAMP system in islets of Langerhans and its role in the control of insulin release. Diabetologia. 1979;16:287–296
  24. Sheja L, Makowski L, Uysal KT. Altered insulin secretion associated with reduced lipolytic efficiency in aP2−/− mice. Diabetes. 1999;48:1987–1994
  25. Brunzell JD, Robertson RP, Lerner RL. Relationships between fasting glucose levels and insulin secretion during intravenous glucose tolerance tests. J. Clin. Endocrinol. Metab. 1976;42:222–229
  26. Kelly ED, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance. Diabetes. 2000;49:677–683

PII: S0306-9877(02)00210-4

Medical Hypotheses
Volume 59, Issue 6 , Pages 655-659 , 12 November 2002

Article Tools